Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

May 13, 2024

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2025

Conditions
ThrombocytopeniaStem Cell Transplant Complications
Interventions
DRUG

avatrombopag

The avatrombopag 20mg/d will be orally taken from +D7 after haplo-HSCT until meeting the adjustment indication or to +D60 after haplo-HSCT; When PLT\<50×10\^9/L or PLT transfusion-dependent on the +D30 after haplo-HSCT, increase avatrombopag dosage to 40 mg/d; When PLT≥80×10\^9/L and without PLT transfusion within avatrombopag dosage at 40 mg/d, decrease avatrombopag dosage to 20 mg/d; When PLT≥80×10\^9/L for 7 consecutive days or PLT≥300×10\^9/L and without PLT transfusion, stop avatrombopag; When PLT\<50×10\^9/L or PLT transfusion-dependent after stopping avatrombopag , reuse avatrombopag at 40 mg/d.

DRUG

Placebo

The placebo 20mg/d will be orally taken from +D7 after haplo-HSCT until meeting the adjustment indication or to +D60 after haplo-HSCT; When PLT\<50×10\^9/L or PLT transfusion-dependent on the +D30 after haplo-HSCT, increase placebo dosage to 40 mg/d; When PLT≥80×10\^9/L and without PLT transfusion within placebo dosage at 40 mg/d, decrease placebo dosage to 20 mg/d; When PLT≥80×10\^9/L for 7 consecutive days or PLT≥300×10\^9/L and without PLT transfusion, stop placebo; When PLT\<50×10\^9/L or PLT transfusion-dependent after stopping placebo, reuse placebo at 40 mg/d.

Trial Locations (14)

100044

RECRUITING

Peking University People's Hospital, Beijing

410008

NOT_YET_RECRUITING

Xiangya Hospital, Central South University, Changsha

650100

NOT_YET_RECRUITING

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming

Unknown

NOT_YET_RECRUITING

Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou

RECRUITING

Peking University Shenzhen Hospital, Shenzhen

NOT_YET_RECRUITING

The First Affiliated Hospital, Harbin Medical University, Harbin

NOT_YET_RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

NOT_YET_RECRUITING

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

NOT_YET_RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

NOT_YET_RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

NOT_YET_RECRUITING

Shanxi Tumor Hospital Affiliated to Shanxi Medical University, Taiyuan

NOT_YET_RECRUITING

Tangdu Hospital, PLA Air Force Military Medical University, Xi’an

NOT_YET_RECRUITING

Xinqiao Hospital, Army Military Medical University, Chongqing

NOT_YET_RECRUITING

Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin

All Listed Sponsors
collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

Sichuan Provincial People's Hospital

OTHER

collaborator

First Affiliated Hospital of Harbin Medical University

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

First Affiliated Hospital of Xinjiang Medical University

OTHER

collaborator

Shanxi Bethune Hospital

OTHER

collaborator

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

OTHER

collaborator

Tang-Du Hospital

OTHER

collaborator

The First Affiliated Hospital of Nanchang University

OTHER

lead

Peking University People's Hospital

OTHER